Singapore: Australia on Friday stopped a vaccine trial in phase 1 after several participants developed antibodies for HIV, though it’s not a serious side effect.
The vaccine, developed by University of Queensland (UQ) in collaboration with biotech company CSL, was tested on 216 people. The University has further tested the patients and confirmed that there is no HIV virus present in their body.
Some participants developed antibodies towards fragments of a HIV protein (gp41), which was used to stabilise the vaccine, the University said.
After that, it was decided that phase 2 and 3 trials will not be carried out.
The Australian government had committed to buy 51 million doses of this experimental vaccine and 3 others.
Australian Prime Minister Scott Morrison sounded practical. “What happened today is not a surprise to the Government. We are moving swiftly but not with any undue haste.”
After an embarrassing whitewash, straight into a test by fire. Team India won't find it…
Celebrity couple Abhishek Bachchan and Aishwarya apparently have some problems in their marriage. As news…
Bhubaneswar: A day after indictment of Gautam Adani in the US in a fraud scheme,…
New York: US President-elect Donald Trump on Thursday nominated Pam Bondi, the former attorney general…
Koraput: Police on Friday claimed to have busted a ganja smuggling racket being carried out…
New York: The recent indictment of top executives of Adani Group, including its chairperson Gautam…
Bhubaneswar: The result of the Odisha Teacher's Eligibility Test (OTET)-2024 was announced on Friday. The…
Bhubaneswar: An attempt for an amicable settlement of the dispute, involving Ollywood director Bobby Islam…